House Committee Leaders Warn Pharmaceutical Companies To End Use Of 'Misleading' Advertisements

Main Category: Pharma Industry / Biotech Industry
Also Included In: Public Health
Article Date: 22 May 2008 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 stars

3 (2 votes)

Healthcare Prof:5 stars

5 (1 votes)


House Energy and Commerce Committee Chair John Dingell (D-Mich.) and Oversight and Investigations Subcommittee Chair Bart Stupak (D-Mich.) in a recent letter warned four pharmaceutical companies to end the use of "misleading and deceptive" direct-to-consumer advertisements for medications, CQ HealthBeat reports. The lawmakers sent the letter to Johnson & Johnson, Merck, Pfizer and Schering-Plough, as well as the Pharmaceutical Research and Manufacturers of America.

In the letter, the lawmakers asked the pharmaceutical companies to end the use of health care professionals in DTC ads and to wait for two years before they air such ads for new medications, among other requests. According to Dingell, the lawmakers sent the letter after pharmaceutical industry representatives failed to assure them of their efforts to reduce adverse effects of DTC ads at a May 8 hearing of the subcommittee.

Dingell in a statement said, "Marketing department leaders have failed to commit to reducing misleading and deceptive ads, so we're now asking the CEOs to make this agreement." Stupak said, "We intend to make certain that drug companies market their product properly in order to protect American consumers from manipulative commercials designed to mislead and deceive for profit."

Ken Johnson, senior vice president of PhRMA, said that the group will maintain "honest and open dialogue" with lawmakers over DTC ads, which he said "inform patients potentially suffering from disease" and help the "entire health care system in the U.S. by encouraging patients to seek medical attention that may help them manage their conditions and avoid unneeded hospital stays or surgeries" (Cooley, CQ HealthBeat, 5/20).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our pharma industry / biotech industry section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "House Committee Leaders Warn Pharmaceutical Companies To End Use Of 'Misleading' Advertisements." Medical News Today. MediLexicon, Intl., 22 May. 2008. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/108386.php>

APA
Kaiser. (2008, May 22). "House Committee Leaders Warn Pharmaceutical Companies To End Use Of 'Misleading' Advertisements." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/108386.php.

Please note: If no author information is provided, the source is cited instead.


Pharma Industry / Biotech Industry

Most Popular Articles



Follow Our Pharma Industry News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharma Industry / Biotech Industry Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »